Neoadjuvant (ECOG-ACRIN EA1181 Compass HER2 pCR)

Study Information

Status: Active, Recruiting

Study Details

View study details on clinicaltrials.gov.

Locations

East Bay, Santa Rosa, Modesto, Solano/Vallejo, Palo Alto/Santa Cruz, Greater Sacramento Valley, San Mateo, San Francisco

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Description

(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response

This trial is available at multiple Sutter Locations. Please contact one of the following about Study EA1181

San Francisco: ClinicalResearch@sutterhealth.org

Palo Alto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org

PAMF/Fremont: Tanya Pozniansky pozniat@sutterhealth.org

East Bay: Vivian Leong, RN Leongv@sutterhealth.org

Sacramento: SIMR@sutterhealth.org

Modesto: Stephanie Edmondson edmondsons@sutterhealth.org

Solano-Vallejo Cancer Center: Stephanie Gonzales gonzals1@sutterhealth.org

San Mateo: Stephanie Casal CasalSL@sutterhealth.org and Bonnie Chan ChanBW@sutterhealth.org

Santa Rosa: Patricia Grinnell GrinneP@sutterhealth.org

Principal Investigator

Kristie A. Bobolis, M.D.

Related Studies

Impact of COVID-19 on Cancer Care Management

Study will enhance understanding of cancer care management due to COVID-19.

Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.

Breast Cancer Chemoprevention in Primary Care at Geisinger

Identify PCPs’ awareness of breast cancer risk assessment and breast cancer chemoprevention knowledge, and identify perceived barriers and clinic solutions.

Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS

Dana Farber 13-09-259 DCIS Registry

Molecular Characterization of Breast Cancer with Duct Forming Features

Investigator: Kristie A. Bobolis, M.D.